Ashwagandha KSM-66 600mg | Cortisol, Sleep & HPA-Axis Foundation

The cortisol-and-sleep foundation underneath every longevity stack. KSM-66 ashwagandha — the standardized root extract used in the majority of published positive RCTs — at the 600mg/day dose that produced the cortisol, sleep, strength, and cognition outcomes in the human-trial literature. One capsule daily. Sixty-day supply.

The 30-second answer

• Cortisol is the master accelerator of biological aging. Chronically elevated cortisol suppresses autophagy, accelerates telomere shortening, depletes the NAD+ pool (via CD38 upregulation), dysregulates insulin, shrinks the hippocampus, blunts immune surveillance, and degrades sleep architecture. The four levers most longevity supplements pull on — autophagy, NAD+, glucose, and sleep — are all the same levers chronic cortisol pulls in the opposite direction.
• Ashwagandha is the most-studied way to normalize the HPA axis. Multiple double-blind, placebo-controlled trials show 23-32% reductions in serum cortisol over 8 weeks (Chandrasekhar 2012; Lopresti 2019; Salve 2019), with parallel improvements on perceived-stress and anxiety scales.
• Polysomnography-confirmed sleep changes. Langade et al. measured PSG-tracked sleep onset latency, total sleep time, sleep efficiency, and slow-wave sleep at 600mg KSM-66/day for 8-10 weeks (Langade 2020; Langade 2019). Latency dropped 28-43%; total sleep rose 13-25%; HAM-A anxiety dropped sharply. By instruments, not self-report.
• KSM-66 is the chemistry that produced the trials. Full-spectrum, root-only (no leaves), standardized to ≥5% withanolides, green-chemistry milk-and-water extraction. It is the extract used in the cortisol, sleep, strength, cognition, and fertility studies that generated the modern ashwagandha file.
• Best for: adults whose stress curve is leaking into their sleep, recovery, and longevity stack — and who want the cortisol/HPA layer of the stack done with the chemistry actually used in the trial data.

Why cortisol normalization is a longevity intervention

Cortisol is the hormone that lets you survive a real emergency. When it spikes acutely — physical injury, a tiger, an actual deadline — it does exactly what it should: mobilizes glucose, suppresses non-essential repair, sharpens attention, and steps on inflammation. The problem is not the spike. The problem is that the curve never comes back down.

Chronic cortisol — the kind produced by 21st-century work, sleep deprivation, screen-driven sympathetic tone, and the persistent low-grade alarm state most adults live in — does five things that read like a checklist of accelerated biological aging.

It suppresses autophagy. Autophagy is the cellular cleanup process that recycles damaged proteins and organelles. It's the same process spermidine, fasting, and rapamycin pull on. Cortisol activates mTOR and suppresses AMPK — the inverse of the longevity-program signal. Over years, the result is accumulating cellular debris: misfolded proteins, dysfunctional mitochondria, the molecular signature of aging tissue.

It accelerates telomere shortening. Epel et al. (PNAS, 2004) measured telomere length in mothers of chronically ill children and found ten years of additional cellular aging compared to controls — directly correlated with perceived stress and serum cortisol. Multiple replications since. Cortisol doesn't shorten telomeres in a lab dish; it does so by raising oxidative stress, suppressing telomerase, and accelerating cell-division turnover in immune cells.

It depletes NAD+. Chronic cortisol upregulates CD38 — the enzyme that breaks down NAD+ — and downregulates NAMPT, the rate-limiting enzyme that builds it. The net effect is the same physiology NMN, NR, and apigenin are working against. Cortisol normalization protects the NAD+ pool the rest of the longevity stack is trying to fill.

It degrades sleep architecture. Evening cortisol delays sleep onset and shortens slow-wave sleep — the recovery window where growth hormone, glymphatic clearance, autophagy, and memory consolidation all happen. A broken cortisol curve is functionally equivalent to a 20% sleep deficit, even if you spend eight hours in bed.

It dysregulates the HPA axis itself. Years of high baseline cortisol leads to receptor downregulation and a flattened diurnal curve — high evenings, low mornings, persistent fatigue layered onto persistent over-arousal. This is the picture seen in adrenal-fatigue presentations and in many burned-out high-performers.

The longevity literature has converged on this: if you do not address chronic cortisol, you are running a more expensive supplement protocol against a stronger headwind. Ashwagandha is the most-studied, most-consistent, and most-replicated way to push that curve back into a healthier shape.

Why ashwagandha ended up in serious longevity research

Adaptogens were on the fringe of nutritional science for decades. The reframing came from three converging lines of evidence — all using KSM-66 at 600mg/day, all randomized, all placebo-controlled.

The cortisol data. Chandrasekhar et al. (Indian Journal of Psychological Medicine, 2012) ran a double-blind RCT in 64 chronically stressed adults at 300mg KSM-66 twice daily for 60 days. The treatment group saw a 27.9% drop in serum cortisol vs. 7.9% in placebo, with parallel reductions on the Perceived Stress Scale, the General Health Questionnaire, and the Depression Anxiety Stress Scale. Lopresti et al. (Medicine, 2019) replicated the design in 60 stressed adults at 240mg/day standardized extract for 60 days and found a 23% cortisol reduction with significant DHEA-S preservation — meaning the HPA axis was being normalized rather than blunted. Salve et al. (Cureus, 2019) reported similar cortisol-reduction effects at 600mg/day in 60 stressed adults.

The sleep architecture work. Langade et al. (Cureus, 2019, and Sleep Medicine, 2020) measured polysomnography-confirmed sleep changes in 80 healthy adults and 150 adults with insomnia at 600mg KSM-66 daily for 8-10 weeks. Sleep onset latency dropped 28-43%, total sleep time rose 13-25%, sleep efficiency improved 7-13%, and HAM-A anxiety scores fell sharply — all by instrument, not just self-report. The mechanism is not sedation; it's recovery of the parasympathetic-dominant state that allows slow-wave sleep to occur. This is when autophagy, glymphatic clearance, and growth hormone release happen — the same recovery windows magnesium and the longevity stack depend on.

The body-composition and recovery data. Wankhede et al. (Journal of the International Society of Sports Nutrition, 2015) ran 600mg KSM-66 daily for 8 weeks in 57 men in a resistance training program. The treatment group added 1.5-1.7 kg more muscle, lost more body fat, and added 19-46 kg more on bench/leg press vs. placebo, with parallel testosterone increases. The mechanism most researchers now favor: lower cortisol means less catabolic interference with the anabolic signaling that resistance training drives — adaptogen as recovery amplifier rather than ergogenic stimulant. Salve et al. (Cureus, 2019) saw similar cortisol/testosterone effects at the same dose in 60 stressed adults.

Put together, the ashwagandha file is unusual in supplement literature: dozens of well-designed RCTs, consistent direction of effect, mechanism convergence, and dose-response visible across studies — all pointing to the same conclusion. Cortisol normalization is the single most-leveraged intervention in the foundational layer of a longevity protocol, and ashwagandha is the most-studied way to do it.

Eight mechanisms — what 600mg/day actually does

1. Cortisol regulation. Withanolides modulate the HPA axis at the hypothalamic level — likely by acting on GABAergic tone, which down-regulates corticotropin-releasing hormone (CRH) signaling rather than blocking the cortisol receptor downstream. The result is a healthier diurnal curve: higher morning cortisol (the activating peak you actually want) and lower evening cortisol (the version that keeps you awake at 2 AM). The effect builds over weeks, not minutes.

2. Sleep architecture. Distinct from sedation: ashwagandha doesn't knock you out; it shortens the time it takes to fall asleep and lengthens the time you spend in slow-wave and REM stages. Slow-wave sleep is when the glymphatic system flushes the brain, when growth hormone is released, when memory consolidation happens, and when the autophagy targeted by the rest of the longevity stack is most active.

3. Anxiety and stress resilience. Multiple meta-analyses (Pratte 2014; Akhgarjand 2022) consistently show medium-to-large effect sizes (Cohen's d 0.5-0.8) on anxiety scales — comparable to first-line pharmacological options without the side-effect profile. Mechanism: GABA-mimetic action of withanolides plus reduced cortisol-driven amygdala reactivity.

4. Muscle recovery and strength. The cortisol reduction is itself anti-catabolic, but ashwagandha also independently raises serum testosterone in men with low-to-normal baseline (Lopresti 2019, ~14% increase) and improves VO₂ max (Choudhary 2015, ~13% increase in trained athletes at 12 weeks). Useful even in non-lifting protocols because the same anabolic signaling preserves lean mass through the decade where sarcopenia begins — a key longevity outcome.

5. Cognitive function. Choudhary et al. (Journal of Dietary Supplements, 2017) measured working memory, reaction time, and executive function in 50 adults with mild cognitive impairment at 600mg/day for 8 weeks. All three domains improved significantly vs. placebo. Mechanism is multifactorial — reduced inflammation, normalized cortisol (chronic high cortisol is hippocampotoxic), and direct neuroprotection from withanolides shown in cell-culture and rodent work.

6. Immune modulation. Mikolai et al. (Journal of Alternative and Complementary Medicine, 2009) and follow-up work show increased CD4+ counts, improved natural-killer cell activity, and lower inflammatory cytokine load — the immune profile is shifted toward surveillance rather than chronic low-grade inflammation. Relevant because chronic stress is directly immunosuppressive, and immune dysregulation is a core hallmark of aging.

7. Thyroid support (subclinical hypothyroidism). Sharma et al. (Journal of Alternative and Complementary Medicine, 2018) ran 600mg/day in 50 patients with subclinical hypothyroidism for 8 weeks and found significant T3 and T4 increases with TSH normalization. The same mechanism is a contraindication in hyperthyroidism — see the contraindications section. The thyroid effect is real and clinically measurable, and it is why ashwagandha is one of the few adaptogens with a published thyroid safety profile worth taking seriously in either direction.

8. Fertility and reproductive hormones. Ambiye et al. (Evidence-Based Complementary and Alternative Medicine, 2013) measured semen parameters in 46 oligospermic men at 675mg/day for 90 days and reported significant improvements in sperm count, motility, and serum testosterone vs. baseline. The fertility data builds on the testosterone-and-cortisol work: lower cortisol relieves some of the suppression on the HPG axis, and the gonadotropin signal moves accordingly. Practical relevance for the longevity stack: testosterone, sperm parameters, and reproductive hormones decline measurably with age, and the cortisol/HPA layer is one of the few interventions that touches all three.

The clinical evidence — what the trials actually measured

Two patterns stand out across the literature. First, dose convergence: the trials that produced the most reliable cortisol, sleep, strength, and cognition outcomes all clustered at 300-600mg/day of standardized KSM-66 — the dose this product delivers in one capsule. Second, time course convergence: most outcomes are visible at 8 weeks, several earlier (sleep is fastest), and the cortisol effect is robust at 4-8 weeks of continuous use.

Why KSM-66 — and what to ignore on the label

Most of what's sold as "ashwagandha" is one of three different things, and the differences matter. The cheapest products on the shelf are not the same molecules that produced the trial outcomes above.

Why root-only matters. Leaves are higher in withaferin A, which is more cytotoxic than the root-dominant withanolide profile. Useful in some research contexts (cancer pharmacology) but not the chemistry that produced the cortisol/sleep/strength file. KSM-66 specifically excludes leaves to preserve the root chemistry.

Why solvent matters. Traditional Ayurveda extracts ashwagandha in milk. KSM-66 uses a milk-and-water green-chemistry process that does not introduce acetone, hexane, or ethanol residues into the finished extract. This is a meaningful quality difference that does not show up on the standardization spec but does show up in third-party residual-solvent testing.

Why 5% (not 10%) full-spectrum. Higher-percentage standardizations are achieved by enriching certain withanolides at the expense of others. The 5% full-spectrum profile preserves the relative proportions of withaferins, withanosides, and withanolide glycosides found in the whole root — which is the chemistry that the 600mg-per-day clinical-trial doses correspond to. A 10% leaf-and-root extract at 600mg is not the same molecular payload, and the trial data does not transfer directly.

The 600mg/day target in this product matches the dose used in the largest body of positive trial data — including all of the sleep, strength, and cognition outcomes above — using the specific standardized extract that produced those outcomes.

What's in the bottle

• KSM-66 Ashwagandha Root Extract — 600mg per serving (1 capsule daily; 60 capsules / 60-day supply)
• Standardized to ≥5% withanolides by HPLC
• Root-only (no leaves) — preserves the chemistry used in the published RCTs
• Green-chemistry milk-and-water extraction; no chemical solvent residues
• Vegetable cellulose capsule (HPMC) — vegan, kosher
• No magnesium stearate, no silicon dioxide, no titanium dioxide, no artificial colorants
• No gluten, no soy, no dairy in the finished capsule, no GMOs
• Manufactured in a U.S. cGMP-certified facility, tested for heavy metals (ICP-MS), pesticides, and microbial load

If you've read any of the other product pages in this catalog, you've seen the same panel discipline: clinical-trial doses, the standardized form actually used in the trials, no proprietary blends, no stimulants stacked in to manufacture a "feel," and nothing in the capsule that doesn't need to be there.

How to take it — three protocols

Default protocol (most users). 1 capsule (600mg KSM-66) daily, with food, ideally with breakfast or lunch. This is the dose used across most of the cortisol, sleep, and cognition studies. Start here unless you have a specific reason to move it.

Sleep-priority protocol. If your primary goal is sleep architecture — falling asleep faster, staying asleep, more time in slow-wave sleep — switch to evening dosing (with dinner or 60-90 minutes before bed). The cortisol-lowering effect compounds with the natural evening cortisol drop and produces more noticeable subjective sleep changes within the first 2 weeks. Pair with Magnesium Glycinate 400mg at the same evening time slot — the two compounds work on complementary halves of the parasympathetic switch (GABA tone via different pathways, and the sympathetic-to-parasympathetic transition).

Strength/recovery protocol. If your primary goal is the muscle, strength, or VO₂ max effects (Wankhede 2015 / Choudhary 2015 outcomes), 1 capsule daily, with the meal closest to your training session, for at least 8-12 weeks. The strength and body-composition signal is durable — most published trials show continued improvement across the trial window without plateau. Stack with Creatine Monohydrate and Magnesium Glycinate for a foundational strength-and-recovery base.

Time to effect. Sleep effects typically show within 1-2 weeks. Cortisol normalization is measurable in serum at 4 weeks and most pronounced by 8 weeks. Strength/body-composition changes follow the trial timeline — visible at 8 weeks, most pronounced at 12. This is not a same-day compound.

Cycling. The published RCTs run 8-12 weeks of continuous use without tolerance development or rebound on discontinuation. Most clinical practitioners run it continuously through stressful seasons and de-emphasize during low-stress periods rather than formally cycling. There is no withdrawal pattern in the published literature.

Stacking with the True Health Protocol catalog

Ashwagandha is the cortisol/HPA-axis foundational layer. It pairs naturally with the rest of the catalog because cortisol normalization protects nearly every downstream longevity intervention.

• Sleep stack. Ashwagandha + Magnesium Glycinate 400mg + Glycine 1500mg in the evening. The three highest-evidence non-prescription sleep compounds, with no overlapping mechanism — GABA tone, NMDA modulation, and parasympathetic transition.
• NAD+ protection stack. Ashwagandha alongside any of the NAD+ line (NMN 1000mg, NAD+ Pure Focus 1000mg, or the Liposomal NAD+ Ultimate). Chronic cortisol upregulates CD38 and depletes the NAD+ pool faster than NMN can refill it — fixing the cortisol leak first compounds the return on the precursor.
• Strength and sarcopenia-prevention stack. Ashwagandha + Creatine Monohydrate 1000mg + Omega-3 2000mg. The Wankhede 2015 trial protocol effectively, plus the omega-3 anti-inflammatory base for recovery.
• Foundational longevity layer. Ashwagandha + Magnesium Glycinate + Omega-3 + Vitamin D3+K2. The four-product foundational layer that should sit underneath any longevity protocol — cortisol, sleep mineral, membrane/inflammation, and hormone substrate. The targeted longevity compounds sit on top of this base.
• Cognitive-protection stack. Ashwagandha + Omega-3 + NAC 600mg. Cortisol normalization (hippocampal preservation), DHA membrane support, and glutathione precursor — three different angles on chronic stress and cognitive aging.

If you're new to the catalog, the foundational layer above is the suggested starting place. Targeted compounds — senolytics, mitochondrial agents, NAD+ precursors — work better in a body whose baseline cortisol, magnesium, omega-3, and D3 status are already in range.

Cortisol, inflammation, and the silent acceleration of biological age

The cortisol-and-inflammation feedback loop is one of the better-described drivers of accelerated biological aging in the modern aging literature. The mechanism runs in both directions and is harder to break with isolated interventions than most people expect.

Cortisol drives inflammation in the long run. In the short term, cortisol is anti-inflammatory — that's why hydrocortisone is a topical treatment for inflammation. But chronically elevated cortisol leads to glucocorticoid receptor desensitization in immune cells, which paradoxically raises baseline inflammatory tone over months and years. This is a well-described mechanism behind why chronic stress correlates with elevated CRP, IL-6, and TNF-α — the same inflammatory markers that map onto cardiovascular risk, cognitive decline, and mortality.

Inflammation drives cortisol back up. Inflammatory cytokines (especially IL-1β and IL-6) signal the hypothalamus to release CRH, which raises ACTH and pushes cortisol back up. The system is bidirectional. Once it gets stuck in a high-cortisol/high-inflammation steady state, breaking either side moves the other.

Why this matters for longevity. "Inflammaging" — chronic low-grade inflammation that increases with age — is one of the named hallmarks of aging in the Lopez-Otin framework. It is mechanistically tied to nearly every other hallmark: it accelerates cellular senescence (the target of senolytics like fisetin and quercetin), it depletes NAD+ (via CD38 again), it suppresses autophagy, and it increases the rate of DNA damage. Cortisol normalization is one of the few interventions that pulls on inflammaging from the upstream side rather than treating individual cytokines downstream.

Ashwagandha doesn't replace omega-3, doesn't replace exercise, doesn't replace sleep hygiene. But it sits at the upstream point of one of the strongest inflammatory drivers most people never address.

Hormones — testosterone, thyroid, and reproductive aging

The hormonal panel is where ashwagandha gets interesting and also where it gets specific contraindications. Worth understanding both before starting.

Testosterone. Multiple trials in men with low-to-normal baseline testosterone show 14-22% increases at 600mg/day for 8-16 weeks (Lopresti 2019, Ambiye 2013, Wankhede 2015). The mechanism is most likely a combination of cortisol reduction (cortisol and testosterone share precursor pregnenolone, and chronic cortisol diverts pregnenolone away from sex-hormone synthesis) plus modest direct gonadotropin support. The effect is small to moderate in healthy men and largest in men with stress-driven suppression at baseline.

DHEA-S preservation. Lopresti 2019 noted that ashwagandha's cortisol-lowering effect did not flatten DHEA-S — meaning the HPA axis was being normalized, not blunted. Important because some adaptogens (and many pharmacological cortisol-lowering interventions) come at the cost of generalized adrenal output, including DHEA — which is the upstream sex-hormone precursor and an independently-tracked aging marker.

Thyroid (T3, T4, TSH). Sharma 2018 measured thyroid panel changes at 600mg/day in 50 patients with subclinical hypothyroidism: T3 +41%, T4 +20%, TSH normalized over 8 weeks. The effect is real and clinically measurable. This is good news in subclinical hypothyroidism (a common age-related slow drift) and a contraindication in hyperthyroidism. If you take levothyroxine, talk to your physician — dose adjustment may be needed.

Female reproductive hormones. Smaller body of literature than the male testosterone work. Dongre 2015 and Gopal 2021 reported sexual-function score improvements in women at 600mg/day for 8 weeks, with parallel reductions in stress markers. Mechanism not fully characterized but consistent with the cortisol/HPA-axis mechanism rather than a direct estrogenic effect.

Sperm parameters and male fertility. Ambiye 2013 in 46 oligospermic men at 675mg/day for 90 days reported substantial improvements in sperm count (+167%), motility (+57%), volume, and serum testosterone (+17% vs baseline). The fertility effect is large in the published trials but should be interpreted with the usual caveats: oligospermic populations have more room to improve, and follow-on trials in larger cohorts are ongoing.

Practical note: if your goal is fertility specifically, see also CoQ10 400mg — the egg- and sperm-quality literature on ubiquinone is one of the most reliable threads in the male/female fertility supplement space, and it stacks cleanly with ashwagandha because the mechanisms (mitochondrial energy + HPA cortisol suppression) are non-overlapping.

What you'll feel and when — week by week

This section is about subjective experience. Lab markers (cortisol, T3, testosterone) move on their own timeline and require blood draws to verify; the subjective experience is what most people are tracking day-to-day.

• Week 1. Subtle. Some users report a slight settling of the "buzzing" baseline anxiety on day 3-5. Sleep changes can begin to appear at the end of the first week. No dramatic shift; if you're expecting one, you'll think it's not working. The cortisol curve is still moving.
• Week 2. Sleep onset latency starts shortening for many users. Subjective stress reactivity to mid-tier stressors (a tense email, a missed deadline) may feel slightly less spiky. Most users describe this stage as "I noticed I didn't get as wound up about [thing] as I usually would."
• Week 4. Cortisol normalization is measurable in serum at this point in the trial data. Subjectively: improved sleep architecture (more refreshed mornings), more stable mid-afternoon energy, less of the 4-5pm crash. Anxiety scale scores in the trials drop most rapidly through this window.
• Week 8. The peak of the cortisol-reduction effect in the published trials. Subjective stress resilience is meaningfully different. For users on the strength/recovery protocol, training recovery starts visibly improving. Sleep is at its best window. Cognitive measures (working memory, reaction time) are starting to register on the Choudhary trial timeline.
• Week 12+. Body composition and strength changes most pronounced for users who are training. Long-term users describe a steadier baseline rather than dramatic peaks — the system is running closer to where it should run, rather than producing an overlay of "feeling better" on top of the same dysregulated baseline.

If nothing has changed by week 6: First, double-check you're taking it consistently with food (withanolides are lipophilic — empty-stomach dosing reduces absorption substantially). Second, consider whether your baseline cortisol is actually the limiting factor for whatever you're tracking. Ashwagandha is an HPA-axis intervention; it does not address sleep apnea, iron deficiency, low ferritin, untreated thyroid disease, or chronic over-caffeination. If those are present, they will overshadow any cortisol effect.

Who should not take this

Adaptogens are mild compared to pharmaceuticals, but ashwagandha has a real interaction profile and a few hard contraindications. The thyroid and immune effects in particular are more substantive than most "natural" supplement interactions.

• Pregnancy and breastfeeding. Ashwagandha is uterotonic in animal models and has been used historically as an abortifacient in some traditions. Do not take if pregnant, planning pregnancy, or breastfeeding.
• Autoimmune conditions. Ashwagandha is immunostimulatory — it raises CD4+ counts and shifts immune tone toward activity. In autoimmune conditions (Hashimoto's thyroiditis, lupus, MS, RA, Sjögren's, type 1 diabetes), this is not what you want. Discuss with your physician before adding.
• Thyroid medication and hyperthyroidism. Multiple trials show ashwagandha raises T3 and T4. Useful in subclinical hypothyroidism (Sharma 2018), problematic in hyperthyroidism, and a real interaction with levothyroxine — it can require dose reduction. Check with your endocrinologist if you're on thyroid medication.
• Sedatives, benzodiazepines, alcohol. Additive effects on GABAergic tone. The combination is not dangerous in the way mixing benzodiazepines and opioids is dangerous, but it can be more sedating than either alone.
• Surgery. Discontinue at least 2 weeks before scheduled surgery — ashwagandha can interact with anesthesia and may have mild blood-pressure-lowering effects.
• Liver disease. Rare hepatotoxicity case reports exist, mostly with combination products and unstandardized leaf-containing extracts; monitor LFTs if you have pre-existing liver disease. The KSM-66 root-only standardized extract has the cleanest safety profile in this category.
• Children. Insufficient pediatric safety data for chronic supplementation. Use only on physician guidance.

If you take any prescription medication or have a chronic condition, run this past your physician before starting. This is true of every supplement, and especially true of a compound that touches the HPA axis and thyroid.

Frequently asked

How is this different from Sensoril or generic ashwagandha? KSM-66 is full-spectrum root extract standardized to ≥5% withanolides, used in the majority of the published positive trials on cortisol, sleep, strength, and cognition. Sensoril is a leaf-and-root extract standardized to ≥10% withanolides — different chemistry, different research base, more emphasis on relaxation/anxiolytic outcomes than on the strength/recovery profile. Generic root powder typically contains 0.1-0.3% withanolides — you would need 3-5 grams per day to match the clinical-trial dose.

Will this make me sleepy during the day? Not in most users. Ashwagandha is classified as an adaptogen rather than a sedative — the cortisol effect normalizes the diurnal curve (higher morning, lower evening) rather than blunting alertness. A small minority of users do report drowsiness; if so, switch the dose to evening.

Ashwagandha or Rhodiola? Different mechanisms, different use cases. Rhodiola is a fast-acting acute stress and fatigue compound — better for "pre-deadline" or "pre-workout" same-day use. Ashwagandha works on chronic baseline cortisol and sleep architecture over weeks. They can be stacked, and many practitioners use Rhodiola situationally and ashwagandha daily.

Does it lower testosterone? The opposite. The strength and male-fertility trials show 14-17% testosterone increases at 8-16 weeks (Lopresti 2019, Ambiye 2013), likely via cortisol reduction (cortisol and testosterone share precursor pregnenolone) plus modest direct gonadotropin support.

Take with food or empty stomach? With food. Withanolides are lipophilic — fat in the meal improves absorption. The clinical trials specified with-meal dosing.

How long until I notice anything? Sleep changes — 1 to 2 weeks. Stress/anxiety reduction — 2 to 4 weeks, building. Cortisol normalization on serum tests — 4 to 8 weeks. Strength/recovery changes — 8 to 12 weeks. This is a re-tune-the-system compound, not a stimulant.

Can I take it with NMN, resveratrol, and the rest of the longevity stack? Yes. There are no known mechanistic conflicts. In fact, the cortisol/CD38 interaction means ashwagandha protects the NAD+ pool that NMN, NR, and apigenin are working to fill. Most longevity practitioners run it as a foundational layer underneath the targeted compounds.

Can I take it with caffeine? Yes. The cortisol-lowering and caffeine-driven adrenergic tone do not directly conflict. If anything, ashwagandha can take some of the edge off the cortisol-spike side of caffeine without blunting the adenosine-receptor effect on alertness.

Does it work for "anxiety" specifically? The published anxiety trials show medium-to-large effect sizes on standardized anxiety scales (HAM-A, DASS) at 600mg/day for 6-8 weeks. It is not a benzodiazepine — it does not produce acute anxiolysis. It changes baseline reactivity over weeks. For acute anxiety, this is the wrong tool; for chronic stress-driven anxiety, it has one of the strongest evidence bases in the supplement space.

Should I cycle it? The published trials run 8-12 weeks of continuous use without tolerance development or rebound. There is no published evidence supporting cycling for safety or efficacy reasons. Most clinical practitioners run it continuously through high-stress periods and de-emphasize during low-stress periods.

What if I miss a dose? No need to double up. The cortisol-normalization effect is a long-term shift in the HPA-axis set point, not a same-day pharmacological action. Resume the next day at the normal dose.

Can women take it? Yes — outside of pregnancy and breastfeeding. The female-population trials are smaller than the male trials but consistently show stress and sleep benefits at 600mg/day, with no signal of estrogen disruption or menstrual irregularity in the published literature. The thyroid contraindication applies to women as it does to men.

Why is the dose lower than what I see in some "high-potency" products? Because the dose used in the published RCTs is 300-600mg/day. Higher doses (1000-2000mg/day) appear in some products without corresponding human-trial data; the marginal benefit above 600mg/day is not well-characterized in the literature, and there is some animal data suggesting higher doses may push past the optimal dose-response curve. We dose at the level that produced the trial outcomes, not at the level that prints the biggest number on the bottle.

Quality and disclaimer

Manufactured in a U.S. FDA-registered, cGMP-certified facility. Each lot is tested for active withanolide concentration (HPLC), heavy metals (ICP-MS), pesticide residues, and microbial contamination. We use KSM-66 specifically — the standardized extract produced by Ixoreal Biomed in India and used in the majority of the published positive RCTs — rather than a generic root powder or a different standardization, because the chemistry that produced the published outcomes is the chemistry we want in the capsule.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. The information above summarizes published research and is provided for educational purposes; it is not medical advice. Consult your physician before starting any supplement, particularly if you are pregnant, breastfeeding, taking prescription medication, scheduled for surgery, have an autoimmune or thyroid condition, or have a chronic medical condition.